CNBC: Hydroxychloroquine fails to help hospitalized coronavirus patients in US funded study
Hydroxychloroquine, a decades-old malaria drug touted by President Donald Trump, didn’t appear to help hospitalized patients with Covid-19, according to a new observational study.
Researchers say, “Nearly 60%, or 811 of the patients, received the drug within 48 hours and were found, on average, to be more severely ill than those who didn’t receive the drug, the researchers said.”
